GENE vs. ELLE ETF Comparison

Comparison of UBS (IRL) ETF PLC UBS (IRL) ETF GL GEN EQ USD ACC (GENE) to Lyxor Global Gender Eqlty (DR) ETF C USD (ELLE)

GENE

UBS (IRL) ETF PLC UBS (IRL) ETF GL GEN EQ USD ACC

GENE Description

The UBS (Irl) ETF plc – Global Gender Equality UCITS ETF sub-fund is an exchange traded fund incorporated in Ireland. The objective of this share class is to deliver the performance of the Solactive Equileap Global Gender Equality 100 Leaders Net Total Return Index and allow intraday trading.

Grade (RS Rating)

Last Trade

£1,492.80

Average Daily Volume

452

Number of Holdings ^*

* may have additional holdings in another (foreign) market

ELLE

Lyxor Global Gender Eqlty (DR) ETF C USD

ELLE Description

The investment objective of Lyxor Index Fund - Lyxor Global Gender Equality (DR) UCITS ETF is to track both the upward and the download evolution of the "Solactive Equileap Global Gender Equality Nety Total Return Index" denominated in USD in order to offer an exposure to the performance of global leading companies in the field of gender equality.

Grade (RS Rating)

Last Trade

£14.61

Average Daily Volume

5,448

Number of Holdings ^*

* may have additional holdings in another (foreign) market

Performance

Period	GENE	ELLE
30 Days	-0.60%	-2.86%
60 Days	1.21%	0.52%
90 Days	4.35%	2.04%
12 Months	9.91%	6.82%

51 Overlapping Holdings

Symbol	Grade	Weight in GENE	Weight in ELLE	Overlap
0A4S	F	0.64%	0.53%	0.53%
0A6B	B	0.92%	0.6%	0.6%
0FQI	A	1.29%	0.87%	0.87%
0GT1	B	1.05%	0.68%	0.68%
0HEW	D	0.77%	0.57%	0.57%
0HJF	F	1.0%	0.63%	0.63%
0HJI	C	0.94%	0.62%	0.62%
0HOY	A	1.2%	0.78%	0.78%
0I58	F	1.18%	0.79%	0.79%
0IFA	C	1.16%	0.79%	0.79%
0IIF	C	1.1%	0.72%	0.72%
0IIW	F	0.98%	0.64%	0.64%
0J3F	D	0.71%	0.49%	0.49%
0J8Z	F	0.75%	0.53%	0.53%
0K0X	C	0.99%	0.68%	0.68%
0KFX	C	1.0%	0.69%	0.69%
0KU1	A	1.06%	0.74%	0.74%
0KYY	D	0.99%	0.69%	0.69%
0LSZ	F	0.75%	0.49%	0.49%
0M29	A	1.26%	0.85%	0.85%
0M6S	A	1.03%	0.71%	0.71%
0NOF	A	0.96%	0.66%	0.66%
0NRE	C	0.88%	0.62%	0.62%
0NVV	A	0.99%	0.74%	0.74%
0NZM	C	0.94%	0.4%	0.4%
0O7D	F	0.75%	0.48%	0.48%
0OJC	D	0.94%	0.62%	0.62%
0OQV	D	0.9%	0.61%	0.61%
0Q16	A	1.14%	0.79%	0.79%
0Q1S	D	1.14%	0.77%	0.77%
0QLR	C	0.87%	0.56%	0.56%
0R01	A	1.27%	0.88%	0.88%
0R0G	C	0.87%	0.59%	0.59%
0R1B	D	0.72%	0.46%	0.46%
0R1X	B	0.98%	0.66%	0.66%
0R2F	A	1.24%	0.86%	0.86%
0R2Z	D	1.04%	0.71%	0.71%
0R3T	D	1.0%	0.69%	0.69%
0Y0Y	F	0.95%	0.63%	0.63%
ADM	A	1.04%	0.7%	0.7%
AZN	B	0.95%	0.62%	0.62%
DSM	F	1.01%	0.68%	0.68%
ITV	B	0.95%	0.65%	0.65%
NG	C	0.95%	0.65%	0.65%
SSE	C	0.92%	0.63%	0.63%
STAN	B	0.82%	0.54%	0.54%
TATE	C	0.83%	0.57%	0.57%
ULVR	F	0.88%	0.58%	0.58%
VOD	D	0.82%	0.57%	0.57%
WPP	B	0.94%	0.65%	0.65%
XSG	F	0.89%	0.64%	0.64%

GENE Overweight 2 Positions Relative to ELLE

	Symbol	Grade	Weight
	0J5I	C	1.15%
	BRFI	C	1.02%

GENE Underweight 27 Positions Relative to ELLE

Symbol	Grade	Weight
BVA	A	-0.84%
0KEQ	B	-0.84%
0HV2	A	-0.83%
0YO9	A	-0.81%
0HF3	A	-0.81%
0KBK	A	-0.76%
0R1T	C	-0.76%
IIG	B	-0.72%
0R3D	A	-0.69%
GSK	C	-0.68%
0QKU	D	-0.68%
LAND	B	-0.67%
0QCV	C	-0.67%
MNG	F	-0.66%
CCH	A	-0.66%
0IFJ	B	-0.66%
0HB5	A	-0.65%
0O8F	B	-0.65%
0CXC	B	-0.64%
PHNX	F	-0.64%
0G8C	B	-0.6%
SDR	F	-0.58%
0J4X	D	-0.56%
0I8Y	C	-0.56%
0M3Q	F	-0.53%
0O46	D	-0.5%
0IIH	F	-0.49%